Advertisement

September 28, 2010

Navilyst Medical Announces PICC Product Launches

September 29, 2010—Navilyst Medical (Marlborough, MA) announced the United States launch of its triple-lumen Xcela peripherally inserted central catheter (PICC) with pressure-activated safety valve (PASV) technology. The Xcela family of power-injectable PICCs is indicated for short- or long-term peripheral access to the central venous system for intravenous therapy.

According to Navilyst, the new catheter combines the design of the PASV with the material of the Xcela power-injectable PICC. The triple-lumen design provides increased flexibility to perform a variety of procedures, including the power injection of contrast media for computed tomography. The PASV technology is designed to automatically resist backflow to reduce blood reflux that could lead to catheter-related complications.

The company also announced the addition of the Navigator BioNavigation system manufactured by Corpak MedSystems (Wheeling, IL) to its product portfolio in the United States. The Navigator BioNavigation system aids in the accurate placement of PICCs and is compatible with Navilyst Medical's line of PICCs.

Navilyst stated that the Navigator BioNavigation system is designed to help improve procedural efficiency by reducing radiation exposure and the incidence of incorrectly positioned PICCs. The battery operated, hand-held instrument provides an audible and visual indicator to let the clinician know the position of the catheter tip inside the body during the catheter insertion procedure.

In related news, on September 24, VasoNova Inc. (Menlo Park, CA) announced that Navilyst Medical will distribute the VasoNova vascular positioning system (VPS) central venous catheter navigation technology.

VasoNova's VPS offers real-time, intravascular catheter navigation technology that does not require external metal detectors, viewing screens, or subjective interpretation of electrocardiography signals. It is capable of confirming precise catheter tip location using highly sophisticated anatomical location identification algorithms embedded in its technology. These location signatures are identified using highly specific Doppler ultrasound characteristics combined with other patient data. The VPS is compatible with all commonly used PICCs and central venous catheters, stated VasoNova.

Advertisement


September 29, 2010

FDA Clears Simbionix Rehearsal Studio Software

September 29, 2010

FDA Clears Simbionix Rehearsal Studio Software